Search research articles
Contact Us
Filters
Showing results (81-90 of 284) with videos related to
Page
of 29
Sort By:
The American Journal of Clinical Nutrition
|
May 26, 2004
Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms
Susanna C Larsson, Maria Kumlin, Magnus Ingelman-Sundberg, et al.
The American Journal of Psychiatry
|
January 13, 2018
Impact of CYP2C19 Genotype on Escitalopram Exposure and Therapeutic Failure: A Retrospective Study Based on 2,087 Patients
Marin M Jukić, Tore Haslemo, Espen Molden, et al.
Clinical Pharmacology and Therapeutics
|
November 13, 2019
Evaluation of Current Regulation and Guidelines of Pharmacogenomic Drug Labels: Opportunities for Improvements
Rawan Shekhani, Linda Steinacher, Jesse J Swen, et al.
Human Genomics
|
May 26, 2018
Integrating rare genetic variants into pharmacogenetic drug response predictions
Magnus Ingelman-Sundberg, Souren Mkrtchian, Yitian Zhou, et al.
Clinical Pharmacology and Therapeutics
|
May 21, 2005
Identification and phenotype characterization of two CYP3A haplotypes causing different enzymatic capacity in fetal livers
Cristina Rodríguez-Antona, Mary Jande, Anders Rane, et al.
Biochemical and Biophysical Research Communications
|
February 21, 2004
Characterization and tissue distribution of a novel human cytochrome P450-CYP2U1
Maria Karlgren, Maria Backlund, Inger Johansson, et al.
Stem Cells and Development
|
September 14, 2012
Hepatic differentiation and maturation of human embryonic stem cells cultured in a perfused three-dimensional bioreactor
Louise Sivertsson, Jane Synnergren, Janne Jensen, et al.
Drug News & Perspectives
|
April 5, 2003
Recent Progress in Drug Metabolism Research
Eleni Aklillu, Mats Hidestrand, Magnus Ingelman-Sundberg, et al.
Cells
|
January 21, 2023
The Role of CTGF in Liver Fibrosis Induced in 3D Human Liver Spheroids
Sara Redenšek Trampuž, Sander van Riet, Åsa Nordling, et al.
Clinical Pharmacology and Therapeutics
|
April 1, 2021
Evaluation of the CYP2D6 Haplotype Activity Scores Based on Metabolic Ratios of 4,700 Patients Treated With Three Different CYP2D6 Substrates
Marin M Jukić, Robert L Smith, Espen Molden, et al.
Page
of 29
Search research articles
Search
Showing results (81-90 of 284) with videos related to
Sort By:
Page
of 29
The American Journal of Clinical Nutrition
|
May 26, 2004
Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms
Susanna C Larsson, Maria Kumlin, Magnus Ingelman-Sundberg, et al.
The American Journal of Psychiatry
|
January 13, 2018
Impact of CYP2C19 Genotype on Escitalopram Exposure and Therapeutic Failure: A Retrospective Study Based on 2,087 Patients
Marin M Jukić, Tore Haslemo, Espen Molden, et al.
Clinical Pharmacology and Therapeutics
|
November 13, 2019
Evaluation of Current Regulation and Guidelines of Pharmacogenomic Drug Labels: Opportunities for Improvements
Rawan Shekhani, Linda Steinacher, Jesse J Swen, et al.
Human Genomics
|
May 26, 2018
Integrating rare genetic variants into pharmacogenetic drug response predictions
Magnus Ingelman-Sundberg, Souren Mkrtchian, Yitian Zhou, et al.
Clinical Pharmacology and Therapeutics
|
May 21, 2005
Identification and phenotype characterization of two CYP3A haplotypes causing different enzymatic capacity in fetal livers
Cristina Rodríguez-Antona, Mary Jande, Anders Rane, et al.
Biochemical and Biophysical Research Communications
|
February 21, 2004
Characterization and tissue distribution of a novel human cytochrome P450-CYP2U1
Maria Karlgren, Maria Backlund, Inger Johansson, et al.
Stem Cells and Development
|
September 14, 2012
Hepatic differentiation and maturation of human embryonic stem cells cultured in a perfused three-dimensional bioreactor
Louise Sivertsson, Jane Synnergren, Janne Jensen, et al.
Drug News & Perspectives
|
April 5, 2003
Recent Progress in Drug Metabolism Research
Eleni Aklillu, Mats Hidestrand, Magnus Ingelman-Sundberg, et al.
Cells
|
January 21, 2023
The Role of CTGF in Liver Fibrosis Induced in 3D Human Liver Spheroids
Sara Redenšek Trampuž, Sander van Riet, Åsa Nordling, et al.
Clinical Pharmacology and Therapeutics
|
April 1, 2021
Evaluation of the CYP2D6 Haplotype Activity Scores Based on Metabolic Ratios of 4,700 Patients Treated With Three Different CYP2D6 Substrates
Marin M Jukić, Robert L Smith, Espen Molden, et al.
Page
of 29